4.1476
Aquestive Therapeutics Inc (AQST) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
14.71%
10.00
|
8.72 | 11.87 | 13.54 | 20.10 |
Cost Of Revenue |
24.89%
4.561
|
3.652 | 4.52 | 4.437 | 4.526 |
Gross Profit |
7.38%
5.442
|
5.068 | 7.347 | 9.105 | 15.57 |
|
31.20%
16.81
|
24.43 | 20.93 | 17.39 | 15.52 |
Benefits Costs and Expenses |
25.59%
23.55
|
31.65 | 28.94 | 25.05 | 22.84 |
Costs And Expenses |
23.91%
21.37
|
28.09 | 25.45 | 21.83 | 20.04 |
Depreciation and Amortization |
0.72%
0.14
|
0.139 | 0.147 | 0.159 | 0.205 |
Operating Income/Loss |
41.30%
-11.37
|
-19.36 | -13.58 | -8.29 | 0.055 |
Income/Loss From Continuing Operations Before Tax |
40.92%
-13.55
|
-22.93 | -17.07 | -11.51 | -2.745 |
Income Tax Expense/Benefit |
-
|
- | -0.014 | - | - |
Income/Loss From Continuing Operations After Tax |
40.92%
-13.55
|
-22.93 | -17.05 | -11.51 | -2.745 |
|
40.92%
-13.55
|
-22.93 | -17.05 | -11.51 | -2.745 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4.01%
99.33
|
95.50 | 1.5019 | 91.08 | 90.91 |
Diluted Average Shares |
4.01%
99.33
|
95.50 | 1.5019 | 91.08 | 90.91 |
Basic Earnings Per Share |
41.67%
-0.14
|
-0.24 | -0.19 | -0.13 | -0.03 |
Diluted Earnings Per Share |
41.67%
-0.14
|
-0.24 | -0.19 | -0.13 | -0.03 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):